期刊文献+

二芳基咪唑类化合物选择性环氧合酶-2(COX-2)抑制性的QSAR研究

A QSAR study of 1,2-diarylimidazole cyclooxygenase-2 inhibitors
原文传递
导出
摘要 应用HyperChem7.0计算与二芳基咪唑类化合物选择性环氧化酶(COX-2)的抑制性相关的量化参数以及自己设计的结构编码参数,对52种1,2-二芳基咪唑化合物的抑制性做QSAR研究。使用逐步回归筛选出影响抑制性的主要参数分子偶极矩μ、分子疏水参数logP和编码参数R_2、R_5和R_7建立QSAR方程。经留三法验证,检验结果相关系数R为0.9155,剩余标准偏差s为0.3601,与回归拟合得到的R=0.9357,s=0.3157接近,表明所建QSAR方程预测效果较好,稳定性较高。对筛选参数的分析表明,μ、logP主要通过影响化合物的脂溶性,R_2、R_5通过影响化合物的空间结构,R_7则通过化合物与COX-2对应活性位点氢键作用的变化,分别对化合物对COX-2的抑制性产生影响。 The quantitative structure activity relationship(QSAR)of 52 1,2-diarylimidazole inhibitors is set up with some quantum-chemical parameters calculated by HyperChem 7.0 students and self-designed structure descriptor codes.The quantum-chemical parameters(μ and logP)and the structure descriptors code(R2,R5,and R7)are selected by stepwise regression.The predicting model has a correlation coefficient(R)of 0.9357 and residual standard error(s)of 0.3157.The performance of the QSAR equation is tested by leave-three-out procedure(LTO),and the correlation coefficient R and standard error(s)are 0.9155 and 0.3610 respectively.It shows that the QSAR model has good stability and predictability.The study indicates that the parameters(μ,logP )influence the in hibitor of the compound in fat-soluble,the parameters( R2,R5)influence the inhibitor of the compound in space effect and the param eters(R7)influence the inhibitor of the compound by hydrogen bond action between the active site of cyclooxygenase-2 and compound.
出处 《计算机与应用化学》 CAS CSCD 北大核心 2008年第3期293-297,共5页 Computers and Applied Chemistry
关键词 二芳基咪唑 量化参数 结构编码参数 定量结构-活性关系 1,2-diarylimidazole quantum-chemical parameter structure descriptor code quantitative structure activity relationship
  • 相关文献

参考文献2

二级参考文献62

  • 1Hawkey C J. COX-2 inhibitors[J]. Lancet, 1999, 353(9149):307-314.
  • 2Picot D, Loll P J, Garaavito R M. The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1[J]. Nature,1994,367(6460):243-249.
  • 3Marnet L J. Recent developments in cyclooxygenase inhibition[C]. Prostaglandins & other Lipid Mediators 68-69,2002. 153-164.
  • 4Kurubail R G, Stevens A M, Gierse J K, et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents[J]. Nature, 1996, 384(6610):644-648.
  • 5Gans K R, Galbrainth W, Roman R J, et al. Antiinflammatory and safety profile of DuP697, a novel orally effective prostaglandin synthesis inhibitor[J]. J Pharmacol Exp Ther, 1990, 254(1):180-187.
  • 6Penning T D, Talley J J, Bertenshaw S R, et al. Synthesis and biological evaluation of the 1,5-Diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-Methylphenyl)-3-(trifluorometh yl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib)[J]. J Med Chem, 1997, 40 (9):1347-1365.
  • 7Kurumbail R G, Stevens A M, Gierse J K, et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents[J]. Nature, 1996, 384. 12(26):644-648.
  • 8Soliva R, Almansa C, Kalko S G, et al. Theoretical studies on the inhibition mechanism of COX-2. Is there a unique recognition site[J]? J Med Chem, 2003, 46(8):1372-1382.
  • 9Plount P M L, Jorgensen W L. Analysis of binding affinities for celecoxib analogues with COX-1 and COX-2 from combined docking and monte carlo simulations and Insight into the COX-2/COX-1 Selectivity[J]. J Am Chem Soc, 2000, 122(39):9455-9466.
  • 10Carmen A, Jose A, Alberto F, et al. Synthesis and structure-activity relationship of a new series of cox-2 selective inhibitors: 1,5-Diarylimidazoles[J]. J Med Chem, 2003, 46(16):3463-3475.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部